Craig Faulks, MD
Orthopaedic Surgery · Washington, DCNPI 1033107883
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (59.5%), education and travel and lodging — rather than concentrated in one kind of arrangement. 16 manufacturers reported payments, led by Arthrex at 34.4% of the total. Reporting peaked in 2021 at $1,948 and has fallen 91.2% since, to $172 in 2025. That places this record below the midpoint for orthopaedic surgery clinicians in DC, where the typical reported total is $4,260.
Across 74 payments — averaging $53.93 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Arthrex$1K
- Stryker$570
- Supreme Orthopedic Systems, LLC$500
- Ferring Pharmaceuticals Inc.$433
- Johnson & Johnson$263
- Smith+Nephew$233
- plus $618 from 10 others
What the payments were for
- Travel & lodging$41710%
- Food & beverage$2,37459%
- Education$1,20030%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Arthrex | 4 | $1,374 |
| Stryker | 14 | $570 |
| Supreme Orthopedic Systems, LLC | 5 | $500 |
| Ferring Pharmaceuticals Inc. | 19 | $433 |
| Johnson & Johnson(2 entities) | 4 | $263 |
| Smith+Nephew | 5 | $233 |
| Conformis, Inc. | 1 | $145 |
| Fidia Pharma USA Inc. | 6 | $141 |
| Avanos Medical | 4 | $84 |
| Amgen | 4 | $74 |
| Pacira Pharmaceuticals Incorporated | 2 | $45 |
| Zimmer Biomet | 1 | $45 |
| Trevena, Inc. | 2 | $27 |
| Bioventus LLC | 1 | $21 |
| ERMI LLC | 1 | $20 |
| Orthofix Medical, Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,991 in reported general payments places this provider in the 45th percentile of 46 orthopaedic surgery providers in District of Columbia.
See all orthopaedic surgery providers in District of Columbia →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Celecoxib | 220 | $5,066 |
| Methylprednisolone | 51 | $385 |
| Meloxicam | 41 | $129 |
| Oxycodone Hcl | 21 | $73 |
| Amoxicillin | 19 | $53 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery in Washington
- Akhil KhannaWashington$2.1M
- Seyed KalantarWashington$886K
- Scott FaucettWashington$610K
- David LuttonWashington$375K
- Savyasachi ThakkarWashington$216K
- Joseph FergusonWashington$84K
- Robert SterlingWashington$38K
- Ryan MurrayWashington$32K
- Robert HenshawWashington$24K
- Sandesh RaoWashington$21K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.